Rectum
Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline - Practical Radiation Oncology
Outcome measures in multimodal rectal cancer trials - The Lancet Oncology
Should we favour the use of 5 × 5 preoperative radiation in rectal cancer - Cancer Treatment Reviews
Inclusion and exclusion criteria for the RECTAL BOOST study a | Download Table
Nonoperative Management of Rectal Cancer: A Modern Perspective
Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States - Advances in Radiation Oncology
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series | SpringerLink
Total Neoadjuvant Therapy for Rectal Cancer: Current Status and Future Directions | SpringerLink
Role of radiotherapy in the treatment of rectal cancer in older patients - European Journal of Surgical Oncology
Organ Preservation Strategies After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
The emerging role of neoadjuvant chemotherapy for rectal cancer - Boland - Journal of Gastrointestinal Oncology
Cancers | Free Full-Text | Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020 - ScienceDirect
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study –
Preoperative short course radiotherapy with concurrent and consolidation chemotherapies followed by delayed surgery in locally advanced rectal cancer: preliminary results. - Abstract - Europe PMC
Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up - ScienceDirect
ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial ...
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ...
